You are here
Clinical Trials: Lung Disease
Each Clinical Trial will open in a new browser window or tab.
Conditions: Pulmonary Fibrosis; Interstitial Lung Disease; Covid19
Intervention: Biological: MON002
Sponsors: Guy's and St Thomas' NHS Foundation Trust; King's College London
Recruiting
Intervention: Biological: MON002
Sponsors: Guy's and St Thomas' NHS Foundation Trust; King's College London
Recruiting
Conditions: Covid19; Novel Coronavirus Pneumonia; Acute Respiratory Distress Syndrome
Interventions: Drug: MSC-exosomes delivered intravenously every other day on an escalating dose: (2:4:8); Drug: MSC-exosomes delivered intravenously every other day on an escalating dose (8:4:8); Drug: MSC-exosomes delivered intravenously every other day (8:8:8)
Sponsor: AVEM HealthCare
Not yet recruiting
Interventions: Drug: MSC-exosomes delivered intravenously every other day on an escalating dose: (2:4:8); Drug: MSC-exosomes delivered intravenously every other day on an escalating dose (8:4:8); Drug: MSC-exosomes delivered intravenously every other day (8:8:8)
Sponsor: AVEM HealthCare
Not yet recruiting
Conditions: Acute Respiratory Distress Syndrome; Covid19
Intervention: Biological: T regulatory cells
Sponsor: Stanford University
Not yet recruiting
Intervention: Biological: T regulatory cells
Sponsor: Stanford University
Not yet recruiting
Conditions: Covid19; Sars-CoV-2 Infection; ARDS, Human; Severe covid19
Interventions: Combination Product: autologous activated platelet-rich plasma; Drug: Avigan
Sponsors: Hayandra Peduli Foundation; Koja Regional Public Hospital
Recruiting
Interventions: Combination Product: autologous activated platelet-rich plasma; Drug: Avigan
Sponsors: Hayandra Peduli Foundation; Koja Regional Public Hospital
Recruiting
Conditions: ARDS, Human; Covid19
Interventions: Biological: Longeveron Mesenchymal Stem Cells (LMSCs); Other: Placebo
Sponsor: Longeveron LLC
Recruiting
Interventions: Biological: Longeveron Mesenchymal Stem Cells (LMSCs); Other: Placebo
Sponsor: Longeveron LLC
Recruiting
Condition: COVID19 ARDS
Interventions: Biological: Ex vivo expanded Wharton's Jelly Mesenchymal Stem Cells; Biological: Placebo
Sponsor: Central Hospital, Nancy, France
Not yet recruiting
Interventions: Biological: Ex vivo expanded Wharton's Jelly Mesenchymal Stem Cells; Biological: Placebo
Sponsor: Central Hospital, Nancy, France
Not yet recruiting
Condition: Acute Respiratory Distress Syndrome
Interventions: Biological: low dose hMSC-Exos; Biological: medium dose hMSC-Exos; Biological: high dose hMSC-Exos; Biological: Dosage 1of hMSC-Exos; Biological: Dosage 2 of hMSC-Exos; Biological: No hMSC-derived exosomes
Sponsors: Ruijin Hospital; Cellular Biomedicine Group Ltd.
Not yet recruiting
Interventions: Biological: low dose hMSC-Exos; Biological: medium dose hMSC-Exos; Biological: high dose hMSC-Exos; Biological: Dosage 1of hMSC-Exos; Biological: Dosage 2 of hMSC-Exos; Biological: No hMSC-derived exosomes
Sponsors: Ruijin Hospital; Cellular Biomedicine Group Ltd.
Not yet recruiting
Condition: Respiratory Distress Syndrome, Adult
Intervention: Drug: agenT-797
Sponsor: AgenTus Therapeutics, Inc.
Recruiting
Intervention: Drug: agenT-797
Sponsor: AgenTus Therapeutics, Inc.
Recruiting
Condition: Corona Virus Infection
Intervention: Biological: T memory cells and NK cells
Sponsors: Instituto de Investigación Hospital Universitario La Paz; Universidad Autonoma de Madrid; Universidad Miguel Hernandez de Elche; Asociación Instituto de Investigación Sanitaria BioCruces; Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana
Recruiting
Intervention: Biological: T memory cells and NK cells
Sponsors: Instituto de Investigación Hospital Universitario La Paz; Universidad Autonoma de Madrid; Universidad Miguel Hernandez de Elche; Asociación Instituto de Investigación Sanitaria BioCruces; Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana
Recruiting
Conditions: Covid19; Acute Respiratory Distress Syndrome
Intervention: Biological: CYP-001
Sponsors: Cynata Therapeutics Limited; Cerebral Palsy Alliance Research Institute
Recruiting
Intervention: Biological: CYP-001
Sponsors: Cynata Therapeutics Limited; Cerebral Palsy Alliance Research Institute
Recruiting
